Nutex Health, Inc.

Total Valuation

Nutex Health, Inc. carries a market capitalization of 875.76M, placing it among publicly traded companies globally. Its enterprise value stands at 861.22M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Share Statistics

Nutex Health, Inc. currently has 6.95M shares outstanding.

Valuation Ratios

Nutex Health, Inc. trades at a trailing price-to-earnings ratio of 6.47. The price-to-sales ratio is 0.71, and the price-to-book ratio stands at -2.61.

Enterprise Valuation

On an enterprise value basis, Nutex Health, Inc. trades at an EV/EBITDA multiple of 2.90 and an EV/FCF ratio of 2.95. The EV/Sales ratio of 0.98 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 3.12 provides insight into valuation relative to core operating earnings.

Financial Position

Nutex Health, Inc. maintains a current ratio of 3.14, meaning it holds 3.1x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 78.97, indicating elevated leverage, while an interest coverage ratio of 14.29 demonstrates strong ability to service its debt obligations.

Financial Efficiency

Taxes

Over the trailing twelve months, Nutex Health, Inc. has paid 57.81M in income taxes, reflecting an effective tax rate of 23.11.

Stock Price Statistics

Nutex Health, Inc.'s stock has gained approximately 9.94991% over the past 52 weeks. The 50-day moving average sits at 121.41, while the 200-day moving average is 121.75.

Income Statement

Over the trailing twelve months, Nutex Health, Inc. generated 879.95M in revenue and converted that into 96.38M in net income, yielding earnings per share of 28.39. EBITDA reached 297.16M, while operating income came in at 276.23M.

Balance Sheet

Nutex Health, Inc. holds 207.35M in cash and equivalents against 349.09M in total debt, resulting in a net debt position of -166.21M. Total book value stands at -239.37M, with working capital of 395.21M providing operational flexibility.

Cash Flow

Nutex Health, Inc. produced 272.68M in operating cash flow over the past twelve months. After subtracting -3.66M in capital expenditures, free cash flow totaled 269.02M - equivalent to 40.99 per share.

Margins

Nutex Health, Inc. operates with a gross margin of 47.47, reflecting its pricing power and cost economics. The operating margin of 31.39 and net profit margin of 10.95 provide insight into operational efficiency.

Dividends & Yields

The company's payout ratio of 28.54 indicates the proportion of earnings distributed to shareholders.

Stock Splits

Nutex Health, Inc.'s most recent stock split took place on July 3, 2024 with a 10:1 split ratio.

Scores

Nutex Health, Inc. posts an Altman Z-Score of 2.82, near the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.